Intuitive Surgical Hits New 52-Week Low at USD 411.83

Intuitive Surgical, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 411.83 on June 1, 2026. This marks a significant decline in the stock's performance, with a one-year return of -1.46%, contrasting sharply with the S&P 500's impressive gain of 28.56% during the same period. The company's market capitalization stands at USD 171,691 million, categorizing it as a large-cap entity. Intuitive Surgical's price-to-earnings (P/E) ratio is currently at 60.00, indicating a premium valuation compared to many of its peers. The firm does not offer a dividend yield, and its debt-to-equity ratio is reported at -0.33, suggesting a unique financial structure. Additionally, the return on equity is a noteworthy 16.17%, while the price-to-book ratio is at 9.63. As the stock navigates this challenging phase, it remains to be seen how these financial metrics will influence its future trajectory in the competitive biotechnology landscape.